{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"5"},{"groupId":"OG001","value":"6"},{"groupId":"OG002","value":"8"},{"groupId":"OG003","value":"4"}],"units":"Participants"}],"description":"Dose Limiting-toxicities (DLT's) is defined as","groups":[{"description":"Participants With a Germline Mutation in Deoxyribonucleic Acid (DNA) Repair Genes","id":"OG000","title":"Comparison Group 1:Participants With a Germline Mutation in Deoxyribonucleic Acid (DNA) Repair Genes"},{"description":"Participants With BRCA1 Associated Protein-1 (BAP1) Somatic Mutations","id":"OG001","title":"Comparison Group 2: Participants With BRCA1 Associated Protein-1 (BAP1) Somatic Mutations"},{"description":"Participants With no tumor tissue available for somatic mutation","id":"OG002","title":"Comparison Group 3: Participants With Neither Germline Mutations Nor BAP 1 Somatic Mutations"},{"description":"Participants With no tumor tissue available for somatic mutation","id":"OG003","title":"Participants Not Classified Under Comparison Groups"}],"paramType":"COUNT_OF_PARTICIPANTS","populationDescription":"Data is grouped as specified per protocol.","reportingStatus":"POSTED","timeFrame":"21 days after enrollment of last subject","title":"Number of Participants With Dose Limiting-toxicities (DLT's)","type":"SECONDARY","unitOfMeasure":"Participants"}